Samsung Biologics' labor union plans to launch a second wave of strikes on Friday, with approximately 400 workers expected to participate, despite a previous court injunction restricting industrial action within the company's production facilities. The strike is scheduled to run through November 27, marking a further escalation in the months-long wage dispute between the two parties, which has already caused the drugmaker cumulative losses of roughly 150 billion won ($112 million).